Folgen
Yuanzhang Fang
Yuanzhang Fang
Postdoctorol Fellow
Bestätigte E-Mail-Adresse bei iu.edu
Titel
Zitiert von
Zitiert von
Jahr
Atractylenolide I enhances responsiveness to immune checkpoint blockade therapy by activating tumor antigen presentation
H Xu, K Van der Jeught, Z Zhou, L Zhang, T Yu, Y Sun, Y Li, C Wan, ...
The Journal of clinical investigation 131 (10), 2021
1032021
Inhibition of breast cancer metastases by a novel inhibitor of TGFβ receptor 1
Y Fang, Y Chen, L Yu, C Zheng, Y Qi, Z Li, Z Yang, Y Zhang, T Shi, J Luo, ...
Journal of the National Cancer Institute 105 (1), 47-58, 2013
1022013
Bcl-xL promotes metastasis independent of its anti-apoptotic activity
S Choi, Z Chen, LH Tang, Y Fang, SJ Shin, NC Panarelli, YT Chen, Y Li, ...
Nature communications 7 (1), 10384, 2016
902016
MAL2 drives immune evasion in breast cancer by suppressing tumor antigen presentation
Y Fang, L Wang, C Wan, Y Sun, K Van der Jeught, Z Zhou, T Dong, ...
The Journal of clinical investigation 131 (1), 2021
732021
Synthesis and biological evaluation of novel tetrahydro-β-carboline derivatives as antitumor growth and metastasis agents through inhibiting the transforming growth factor-β …
C Zheng, Y Fang, W Tong, G Li, H Wu, W Zhou, Q Lin, F Yang, Z Yang, ...
Journal of medicinal chemistry 57 (3), 600-612, 2014
682014
LGR4 modulates breast cancer initiation, metastasis, and cancer stem cells
Z Yue, Z Yuan, L Zeng, Y Wang, L Lai, J Li, P Sun, X Xue, J Qi, Z Yang, ...
The FASEB Journal 32 (5), 2422, 2018
662018
Targeting 17q23 amplicon to overcome the resistance to anti-HER2 therapy in HER2+ breast cancer
Y Liu, J Xu, HH Choi, C Han, Y Fang, Y Li, K Van der Jeught, H Xu, ...
Nature communications 9 (1), 4718, 2018
582018
An organoid-based screen for epigenetic inhibitors that stimulate antigen presentation and potentiate T-cell-mediated cytotoxicity
Z Zhou, K Van der Jeught, Y Fang, T Yu, Y Li, Z Ao, S Liu, L Zhang, ...
Nature biomedical engineering 5 (11), 1320-1335, 2021
562021
Comparative analysis of human protein-coding and noncoding RNAs between brain and 10 mixed cell lines by RNA-Seq
G Chen, K Yin, L Shi, Y Fang, Y Qi, P Li, J Luo, B He, M Liu, T Shi
PloS one 6 (11), e28318, 2011
402011
Heterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase II
Y Li, Y Liu, H Xu, G Jiang, K Van der Jeught, Y Fang, Z Zhou, L Zhang, ...
Nature communications 9 (1), 4394, 2018
382018
Somatic mutation of the cohesin complex subunit confers therapeutic vulnerabilities in cancer
Y Liu, H Xu, K Van der Jeught, Y Li, S Liu, L Zhang, Y Fang, X Zhang, ...
The Journal of clinical investigation 128 (7), 2951-2965, 2018
362018
ST2 as checkpoint target for colorectal cancer immunotherapy
K Van der Jeught, Y Sun, Y Fang, Z Zhou, H Jiang, T Yu, J Yang, ...
JCI insight 5 (9), 2020
322020
Caffeic acid 3, 4-dihydroxy-phenethyl ester induces cancer cell senescence by suppressing twist expression
A Dong, Y Fang, L Zhang, J Xie, X Wu, L Zhang, X Lian, Y Chen, J Luo, ...
Journal of Pharmacology and Experimental Therapeutics 339 (1), 238-247, 2011
272011
MicroRNAs in DNA damage response, carcinogenesis, and chemoresistance
Y Fang, L Zhang, Z Li, Y Li, C Huang, X Lu
International Review of Cell and Molecular Biology 333, 1-49, 2017
222017
Inhibition of non-small cell lung cancer (NSCLC) growth by a novel small molecular inhibitor of EGFR
J Li, H Deng, M Hu, Y Fang, A Vaughn, X Cai, L Xu, W Wan, Z Li, S Chen, ...
Oncotarget 6 (9), 6749, 2015
142015
Metabolic interventions: a new insight into the cancer immunotherapy
T Yu, T Dong, H Eyvani, Y Fang, X Wang, X Zhang, X Lu
Archives of biochemistry and biophysics 697, 108659, 2021
72021
浅谈癌症及其治疗方法
房元章
生物学教学 30 (1), 61, 2005
22005
Author Correction: An organoid-based screen for epigenetic inhibitors that stimulate antigen presentation and potentiate T-cell-mediated cytotoxicity
Z Zhou, K Van der Jeught, Y Fang, T Yu, Y Li, Z Ao, S Liu, L Zhang, ...
Nature Biomedical Engineering, 1-1, 2023
2023
低频脉冲电场对 PC12 细胞酪氨酸氢化酶和多巴胺合成的影响
房元章, 余晓君, 张红锋, 陈树德
细胞生物学杂志 29, 394-398, 2007
2007
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–19